Navigation Links
Highlights from the October 2007 Journal of the American Dietetic Association
Date:10/1/2007

CHICAGO The October 2007 issue of the Journal of the American Dietetic Association contains articles and research studies you may find of interest. Below is a summary of some of this months articles. For more information or to receive a copy of a Journal article, e-mail media@eatright.org.

A Dietary Quality Comparison of Popular Weight Loss Diets

The Alternate Healthy Eating Index measures and compares factors in a persons diet that are strongly linked to reducing risk for cardiovascular disease. According to researchers at the University of Massachusetts who compared the dietary quality of several popular weight-loss plans, none of the plans achieved a perfect AHEI score, but the Ornish, Weight Watchers high-carbohydrate and New Glucose Revolution plans were among the best performers using the AHEI and traditional dietary quality assessments.

The researchers calculated the AHEI from meal plans taken from books or Web sites for the New Glucose Revolution, WeightWatchers, Atkins, South Beach, Zone, Ornish and 2005 U.S. Department of Agriculture MyPyramid plans. Of a maximum possible score of 70, the AHEI scores for each weight-loss plan were:

  • Ornish: 64.6
  • WeightWatchers high-carbohydrate: 57.4
  • New Glucose Revolution: 57.2
  • South Beach Phase 2: 50.7
  • Zone: 49.8
  • MyPyramid: 48.7
  • Weight Watchers high-protein: 47.3
  • Atkins 100-g carbohydrate: 46
  • South Beach Phase 3: 45.6
  • Atkins 45-g carbohydrate: 42.3

The researchers conclude that the AHEI is a valuable tool in selecting a weight-loss plan that maximizes both weight loss and (cardiovascular disease) prevention. Since the study was based on meal plans as described by their creators, the researchers recommend further study to observe what patients actually consume when following a popular wei
'/>"/>

Contact: Jennifer Starkey
media@eatright.org
312-899-4802
American Dietetic Association
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Chennai AIDS Campaign Highlights The Social Neglect Faced By Victims
2. Benzene Slick In China Highlights Water Pollution
3. Homecare Association Highlights Cost-Effectiveness of Medicare and Medicaid
4. Study Highlights Appetite Regulation Pathway, New Hope for Weight Loss
5. Study Highlights How Bacteria Respond To Changes In Environment
6. Highlights from World Transplant Congress
7. Latest IPCC Report Highlights Need for Integrated Climate/human Behavior Models
8. New Critical Path Report Highlights Research Needed to Foster Generic Drug Development
9. New York Legislature Highlights for Awareness of Alzheimers Disease
10. New Critical Path Report Highlights Research Needed to Foster Generic Drug Development
11. EU Drug Regulator Highlights Depression Danger of Weight-loss Pill
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:VitaminSpice Signs Agreement With Former CEO of Wal-Mart Stores Division for US Distribution 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5Health News:New approach to sickle-cell disease shows promise in mice 2
Breaking Medicine Technology:VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3Hair Fairies Kicks Off the Holiday Season With an All Natural Head Lice Product Giveaway 62116 1Hair Fairies Kicks Off the Holiday Season With an All Natural Head Lice Product Giveaway 62116 2Hair Fairies Kicks Off the Holiday Season With an All Natural Head Lice Product Giveaway 62116 3Par Pharmaceutical Announces Results of Its Modified Dutch Auction Tender Offer 62113 1Par Pharmaceutical Announces Results of Its Modified Dutch Auction Tender Offer 62113 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 1Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 9